BILL ANALYSIS                                                                                                                                                                                                    �



                                                                            



           ----------------------------------------------------------------- 
          |SENATE RULES COMMITTEE            |                       AB 2418|
          |Office of Senate Floor Analyses   |                              |
          |1020 N Street, Suite 524          |                              |
          |(916) 651-1520         Fax: (916) |                              |
          |327-4478                          |                              |
           ----------------------------------------------------------------- 
           
                                           
                                    THIRD READING


          Bill No:  AB 2418
          Author:   Bonilla (D), et al.
          Amended:  8/19/14 in Senate
          Vote:     21

           
           SENATE HEALTH COMMITTEE  :  7-0, 6/25/14
          AYES:  Hernandez, Beall, De Le�n, DeSaulnier, Evans, Monning,  
            Nielsen
          NO VOTE RECORDED:  Morrell, Wolk

           SENATE APPROPRIATIONS COMMITTEE  :  6-0, 8/14/14
          AYES:  De Le�n, Gaines, Hill, Lara, Padilla, Steinberg
          NO VOTE RECORDED:  Walters

           ASSEMBLY FLOOR  :  75-1, 5/29/14 - See last page for vote


           SUBJECT  :    Health care coverage:  prescription drugs:  refills

           SOURCE  :     California Healthcare Institute
                      California Pharmacists Association


           DIGEST  :    This bill requires a health care service plan  
          contract or health insurance policy issued, amended, or renewed  
          on or after January 1, 2016, that provides coverage for  
          prescription drug benefits to permit and apply a prorated daily  
          cost-sharing rate to refills of prescriptions that are dispensed  
          by a participating pharmacy for less than the standard refill  
          amount if the prescriber or pharmacist indicates that the refill  
          is in the best interest of the enrollee or insured and is for  
          the purpose of synchronizing the refill dates of the enrollee's  
                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          2

          or insured's medications, provided that certain requirements are  
          satisfied.  This bill also requires a health care service plan  
          contract or health insurance policy issued, amended, or renewed  
          on or after January 1, 2016, that provides coverage for  
          prescription drug benefits to allow for the early refill of  
          covered topical ophthalmic products at 70% of the predicted days  
          of use. 

           ANALYSIS  :    

          Existing law:

          1. Requires health care service plans to be regulated by the  
             Department of Managed Health Care (DMHC) and health insurers  
             to be regulated by the Department of Insurance (CDI).

          2. Requires health care plans and health insurers that cover  
             prescription drug benefits to provide notice in the evidence  
             of coverage and disclosure form to enrollees/insureds  
             regarding whether the plan uses a formulary. 

          3. Limits, for an individual or group health care service plan  
             contract or health insurance policy issued, amended, or  
             renewed on or after January 1, 2015, that provides coverage  
             for prescribed, orally administered anticancer medications  
             used to kill or slow the growth of cancerous cells, the total  
             amount of copayments and coinsurance an enrollee or insured  
             is required to pay for orally administered anticancer  
             medications to $200 for an individual prescription of up to a  
             30-day supply.

          4. Mandates the ten federally required Essential Health Benefits  
             (EHBs) including prescription drug coverage and establishes  
             Kaiser Small Group health plan as California's EHB benchmark  
             plan for non-grandfathered individual and small group health  
             plan contracts and insurance policies.

          This bill:

          1. Requires a health plan contract or insurance policy issued,  
             amended, or renewed on or after January 1, 2016, that  
             provides coverage for prescription drug benefits to  permit  
             and apply a prorated daily cost-sharing rate to the refills  
             of prescriptions that are dispensed by a participating  

                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          3

             pharmacy for less than the standard refill amount if the  
             prescriber or pharmacist indicates that the refill for less  
             than the standard amount is in the best interest of the  
             enrollee or insured and is for the purpose of synchronizing  
             the refill dates of the enrollee's or insured's medications  
             and all of the following apply:

             A.    The prescription drugs being synchronized are covered  
                and authorized by the health plan contract or health  
                insurance policy;

             B.    The prescription drugs being refilled for less than  
                the standard amount are not subject to quantity limits  
                or other utilization management controls that are  
                inconsistent with the synchronization plan, including,  
                but not limited to, controlled substance prescribing and  
                dispensing guidelines intended to prevent misuse or  
                abuse;

             C.    The prescription drugs being synchronized are  
                dispensed by a single participating pharmacy;

             D.    The patient has completed at least 90 consecutive  
                days on the prescription drugs being synchronized;

             E.    The prescription drugs being refilled for less than  
                the standard amount are of a formulation that can be  
                effectively split over the required short fill period to  
                achieve synchronization; and

             F.    The prescriber has not done either of the following  
                with respect to the prescription drugs being refilled  
                for less than the standard amount:

                (1)      Indicated, either orally or in his/her own  
                   handwriting, "No change to quantity," or words of  
                   similar meaning; or

                (2)      Checked a box on the prescription marked "No  
                   change to quantity," and personally initialed the  
                   box or checkmark.

          2. Exempts, from #1) through #4) above, a drug that is not  
             available at a participating community pharmacy due to any of  

                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          4

             the following:

             A.    An industry shortage listed on the Current Drug  
                Shortages Index maintained by the federal Food and Drug  
                Administration (FDA);

             B.    A manufacturer's instructions or restrictions;

             C.    Any risk evaluation and management strategy approved  
                by the FDA; or

             D.    A special shortage affecting the plan's network of  
                participating pharmacies.

          3. Requires a health plan contract or health insurance policy  
             issued, amended, or renewed on or after January 1, 2016, that  
             provides coverage for prescription drug benefits to allow for  
             early refills of covered topical ophthalmic products at 70%  
             of the predicted days of use.

          4. Prohibits anything in this bill from being construed to  
             establish a new mandated benefit or to prevent the  
             application of deductible or copayment provisions in a plan  
             contract.


           FISCAL EFFECT  :    Appropriation:  No   Fiscal Com.:  Yes    
          Local:  Yes


          According to the Senate Appropriations Committee:


        One-time costs of $80,000 and ongoing costs of $70,000 per year  
            for review of insurance plan filings and enforcement by the  
            CDI (Insurance Fund).


        One-time costs of $275,000 and ongoing costs of $40,000 for  
            development of regulations and enforcement by the DMHC  
            (Managed Care Fund).


        Increased health care costs to CalPERS of about $6,000 per year  

                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          5

            due to increased prescription drug benefit costs (various  
            funds) costs.

        Increased health care costs to the Medi-Cal program, due to  
            increased prescription drug costs to Medi-Cal managed care  
            plans of about $155,000 per year (General Fund and federal  
            funds).

           SUPPORT  :   (Verified  8/19/14)

          California Healthcare Institute (co-source)
          California Pharmacists Association (co-source)
          AFSCME, AFL-CIO
          ALS Association
          American Cancer Society 
          Association of Northern CA Oncologists
          BayBio
          BioCom
          Biotechnology Industry Organization (BIO)
          California Association of Area Agencies on Aging
          California Chronic Care Coalition
          California Grocers Association 
          California Health Collaborative
          California Hepatitis C Task Force
          California Optometric Association
          California Pan-Ethnic Health Network
          California Senior Advocates League
          California Senior Legislature 
          California Urological Association
          CAPG - The Voice of Accountable Physician Groups
          Central Drug Store
          Congress of California Seniors 
          Contra Costa County Public Guardian/Conservators Department
          Hemophilia Council of California
          Herndon Pharmacy 
          Huntington's Disease Society of America
          International Foundation for Autoimmune Arthritis
          La Clinica de La Raza, Inc. 
          Latina Breast Cancer Agency
          Latinas Contra Cancer
          Mental Health America of California
          Mental Health Systems 
          National Association for the Advancement of Colored People  
          (NAACP)

                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          6

          National Association of Chain Drug Stores
          National Multiple Sclerosis Society
          Patterson Family Pharmacy 
          Pharmaceutical Research and Manufacturers of American (PhRMA)
          Rehabilitation Services of Northern California (RSNC)
          Rite Aid
          Sacramento Latino Medical Association
          Safeway
          SEIU - UHW (United Healthcare Workers West)
          Spondylitis Association of America
          The Wall Las Memorias
          United Food and Commercial Workers Union
          United Nurses Associations of California/Union of Health Care  
          Professionals
          Walgreens

           OPPOSITION  :    (Verified  8/19/14)

          Aetna
          America's Health Insurance Plans
          Association of California Life and Health Insurance Companies
          Blue Shield
          California Association of Health Plans
          CSAC Excess Insurance Authority
          CVS Caremark 
          Department of Managed Health Care  
          Express Scripts 
          Pharmaceutical Care Management Association 
          United Health Group

           ARGUMENTS IN SUPPORT  :    The author's office states that that  
          poor medication adherence is a major barrier to achieving better  
          patient health outcomes and that this bill streamlines the  
          medication refill process by making it more convenient for  
          patients to pick up all their medications on one trip to the  
          pharmacy and allows patients who run out of eye drops to obtain  
          an early refill.

          ARGUMENTS IN OPPOSITION  :    The California Association of Health  
          Plans (CAHP) opposes the refill synchronization process for  
          prescription drugs because it is confusing and logistically  
          impractical.  CAHP states that requiring plans to accept a  
          pro-rated daily cost-share for early refills is impractical when  
          claims systems are not set up to accept partial service fees.   

                                                                CONTINUED





                                                                    AB 2418
                                                                     Page  
          7

          CAHP claims that plans will have to manually calculate a daily  
          rate for each synchronization and it would complicate the  
          ability to track member payments toward their deductible.

           ASSEMBLY FLOOR  :  75-1, 5/29/14
          AYES:  Achadjian, Alejo, Allen, Ammiano, Bigelow, Bloom,  
            Bocanegra, Bonilla, Bonta, Bradford, Brown, Buchanan, Ian  
            Calderon, Campos, Chau, Ch�vez, Chesbro, Conway, Cooley,  
            Dababneh, Dahle, Daly, Dickinson, Eggman, Fong, Fox, Frazier,  
            Beth Gaines, Garcia, Gomez, Gonzalez, Gordon, Gorell, Gray,  
            Grove, Hagman, Roger Hern�ndez, Holden, Jones, Jones-Sawyer,  
            Levine, Linder, Logue, Lowenthal, Maienschein, Mansoor,  
            Medina, Melendez, Mullin, Muratsuchi, Nazarian, Nestande,  
            Olsen, Pan, Patterson, Perea, John A. P�rez, V. Manuel P�rez,  
            Quirk, Quirk-Silva, Rendon, Ridley-Thomas, Rodriguez, Salas,  
            Skinner, Stone, Ting, Wagner, Waldron, Weber, Wieckowski,  
            Wilk, Williams, Yamada, Atkins
          NOES:  Gatto
          NO VOTE RECORDED:  Donnelly, Hall, Harkey, Vacancy


          JL:d  8/19/14   Senate Floor Analyses 

                           SUPPORT/OPPOSITION:  SEE ABOVE

                                   ****  END  ****



















                                                                CONTINUED